DK0448523T3 - Farmaceutiske præparater med virkning på det cardiovaskulære system, indeholdende 3-methylthiopropionyl-L-carnitin - Google Patents

Farmaceutiske præparater med virkning på det cardiovaskulære system, indeholdende 3-methylthiopropionyl-L-carnitin

Info

Publication number: DK0448523T3
Authority: DK; Denmark
Prior art keywords: methylthiopropionyl; carnitine; cardiovascular system; pharmaceuticals; effect
Prior art date: 1990-03-15

Application number

DK91830083.1T

Other languages

Danish (da)

English (en)

Inventor

Claudio Cavazza

Original Assignee

Sigma Tau Ind Farmaceuti

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-03-15

Filing date

1991-03-11

Publication date

1995-06-06

1991-03-11 Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti

1995-06-06 Application granted granted Critical

1995-06-06 Publication of DK0448523T3 publication Critical patent/DK0448523T3/da

Links

210000000748 cardiovascular system Anatomy 0.000 title abstract 2
239000003814 drug Substances 0.000 title 1
230000000694 effects Effects 0.000 title 1
206010002660 Anoxia Diseases 0.000 abstract 1
241000976983 Anoxia Species 0.000 abstract 1
XLLLEHOVFCWHNB-LLVKDONJSA-N CCCC(=S)[C@](O)(C[N+](C)(C)C)CC([O-])=O Chemical compound CCCC(=S)[C@](O)(C[N+](C)(C)C)CC([O-])=O XLLLEHOVFCWHNB-LLVKDONJSA-N 0.000 abstract 1
206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
206010019280 Heart failures Diseases 0.000 abstract 1
206010021143 Hypoxia Diseases 0.000 abstract 1
230000007953 anoxia Effects 0.000 abstract 1
206010003119 arrhythmia Diseases 0.000 abstract 1
230000006793 arrhythmia Effects 0.000 abstract 1
230000002107 myocardial effect Effects 0.000 abstract 1
208000031225 myocardial ischemia Diseases 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK91830083.1T 1990-03-15 1991-03-11 Farmaceutiske præparater med virkning på det cardiovaskulære system, indeholdende 3-methylthiopropionyl-L-carnitin DK0448523T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT47759A IT1240799B (it)	1990-03-15	1990-03-15	Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare.

Publications (1)

Publication Number	Publication Date
DK0448523T3 true DK0448523T3 (da)	1995-06-06

Family

ID=11262331

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91830083.1T DK0448523T3 (da)	1990-03-15	1991-03-11	Farmaceutiske præparater med virkning på det cardiovaskulære system, indeholdende 3-methylthiopropionyl-L-carnitin

Country Status (8)

Country	Link
US (1)	US5173508A (fr)
EP (1)	EP0448523B1 (fr)
JP (1)	JPH04217656A (fr)
AT (1)	ATE122561T1 (fr)
DE (1)	DE69109721T2 (fr)
DK (1)	DK0448523T3 (fr)
ES (1)	ES2072591T3 (fr)
IT (1)	IT1240799B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1254314B (it) *	1992-03-27	1995-09-14	Sigma Tau Ind Farmaceuti	Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
IT1263004B (it) *	1992-10-08	1996-07-23	Sigma Tau Ind Farmaceuti	Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1276225B1 (it) *	1995-10-17	1997-10-27	Sigma Tau Ind Farmaceuti	Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1276253B1 (it)	1995-12-15	1997-10-27	Sigma Tau Ind Farmaceuti	Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1291113B1 (it) *	1997-03-20	1998-12-29	Sigma Tau Ind Farmaceuti	Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5863940A (en)	1997-12-01	1999-01-26	Sigma-Tau Healthscience S.P.A.	Medicament and therapeutical method for treating idiopathic asthenozoospermia
US6090848A (en) *	1997-12-01	2000-07-18	Sigma-Tau Healthscience S.P.A.	Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
DK0951909T4 (da)	1998-03-19	2011-01-24	Sigma Tau Ind Farmaceuti	Kombinationspræparat omfattende en L-carnitin eller en alkanoyl-L-carnitin, en glycosaminoglycan og/eller bestanddel deraf

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU518617B2 (en) *	1977-04-29	1981-10-08	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Therapeutic application of acetyl-d, 1-carnitine
IT1116037B (it) *	1979-04-23	1986-02-10	Sigma Tau Ind Farmaceuti	Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
IT1145371B (it) *	1980-05-30	1986-11-05	Sigma Tau Ind Farmaceuti	Alcossi-acil carnitine procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT1170862B (it) *	1981-03-31	1987-06-03	Sigma Tau Ind Farmaceuti	Mercaptoacil-carnitine procedimento per la loro preparazione e loro uso terapeutico
IT1177874B (it) *	1984-07-04	1987-08-26	Sigma Tau Ind Farmaceuti	Estere della acetil carnitina,procedimenti per la sua preparazione e composizioni farmaceutiche che lo contengono

1990
- 1990-03-15 IT IT47759A patent/IT1240799B/it active IP Right Grant
1991
- 1991-03-11 DK DK91830083.1T patent/DK0448523T3/da active
- 1991-03-11 ES ES91830083T patent/ES2072591T3/es not_active Expired - Lifetime
- 1991-03-11 AT AT91830083T patent/ATE122561T1/de not_active IP Right Cessation
- 1991-03-11 DE DE69109721T patent/DE69109721T2/de not_active Expired - Fee Related
- 1991-03-11 EP EP91830083A patent/EP0448523B1/fr not_active Expired - Lifetime
- 1991-03-14 JP JP3049907A patent/JPH04217656A/ja active Pending
- 1991-03-14 US US07/669,573 patent/US5173508A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
IT9047759A1 (it)	1991-09-15
EP0448523A2 (fr)	1991-09-25
ES2072591T3 (es)	1995-07-16
EP0448523B1 (fr)	1995-05-17
US5173508A (en)	1992-12-22
JPH04217656A (ja)	1992-08-07
ATE122561T1 (de)	1995-06-15
DE69109721D1 (de)	1995-06-22
HK1005565A1 (en)	1999-01-15
EP0448523A3 (en)	1992-04-15
IT9047759A0 (it)	1990-03-15
IT1240799B (it)	1993-12-17
DE69109721T2 (de)	1995-10-26

Similar Documents

Publication	Publication Date	Title
DE69101954D1 (de)	1994-06-16	Titandioxidsubstrate und deren Herstellung.
SE9903759D0 (sv)	1999-10-18	Pharmaceutically active compounds
DE69107459D1 (de)	1995-03-23	Benzosäure substituierte derivate mit kardiovasculärer wirkung.
KR900700435A (ko)	1990-08-13	신규아민류 및 그 용도
DK0448523T3 (da)	1995-06-06	Farmaceutiske præparater med virkning på det cardiovaskulære system, indeholdende 3-methylthiopropionyl-L-carnitin
NO923721D0 (no)	1992-09-24	4-desoksy-4-epipodophyllotoxin-derivat eller farmasoeytiskakseptabelt salt derav
ES2168384T3 (es)	2002-06-16	Derivados de 2-amino-1,2,3,4-tetrahidronaftaleno activos para el sistema cardiovascular.
NO180230C (no)	1997-03-12	2-amino-1,2,3,4-tetrahydronaftalenderivater med kardiovaskulær aktivitet samt farmasöytiske preparater inneholdende slike
IT8720424A0 (it)	1987-05-07	Procedimento e macchina per il trattamento, in particolare la tintura discontinua, di tessuti in falde.
DE69206247D1 (de)	1996-01-04	Titanaluminid des Gammatyps.
IT1275935B1 (it)	1997-10-24	Derivato di aminotetralina per la terapia di malattie cardiovascolari
NO891046D0 (no)	1989-03-10	Fremgangsmaate for fremstilling av terapeutisk aktive 1,2,4-triazol-derivater.
DE59106215D1 (de)	1995-09-14	Substituierte Aminosäureamid-Derivate, deren Herstellung und Verwendung.
NO162468C (no)	1990-01-10	Analogifremgangsmaate for fremstilling av terapeutisk aktive 12-amino-pyridazino (4[,5[;3,4)-pyrrolo-( 2,1-a)-isokinolinderivater.
FI943875L (fi)	1994-08-23	2,3,4,5-Tetrahydro-1H-3-bentsatsepiinejä ja niiden farmaseuttisesti hyväksyttäviä happoadditiosuoloja
DE68900867D1 (de)	1992-04-02	1,5-benzothiazepinderivate, ihre herstellung und ihre verwendung in der behandlung von kardiovasculaeren stoerungen.
DE3862038D1 (de)	1991-04-25	Mittel gegen pflanzenschaedigende milben auf basis von azomethinen des 2,3-diaminomaleinsaeurenitrils.
GR3025064T3 (en)	1998-01-30	New hydrazino and hydroxyamino-14beta-hydroxyandrostane derivatives active on the cardio-vascular system, processes for their preparation and pharmaceutical compositions containing same
DE59105160D1 (de)	1995-05-18	Substituierte Aminosäureamid-Derivate deren Herstellung und Verwendung.
EE200100675A (et)	2003-02-17	Bispidiini uued arütmiavastased ühendid, mida kasutatakse südame arütmia ravis
AU1691888A (en)	1988-12-08	Compound active in cardiovascular therapy
DE68908838D1 (de)	1993-10-07	Pharmazeutisch wirksame Dithioketen-Derivaten.
ATE100332T1 (de)	1994-02-15	Pharmazeutische zusammensetzung, verwendbar bei der behandlung von herzgefaesserkrankungen.
EE200100679A (et)	2003-02-17	Bispidiini uued arütmiavastased ühendid, mida kasutatakse südame arütmia ravis
RU97108900A (ru)	1999-05-20	Применение этимизола в качестве антиаритмического средства для предупреждения желудочковой экстрасистолии у больных ибс